5-Year Data: DLBCL Treatment Gets High Five

In diffuse large B-cell lymphoma, Pola-R-CHP maintains progression-free survival at 5-year follow-up.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/5-year-data-diffuse-large-b-cell-lymphoma-treatment-gets-2025a1000r4p?src=rss

Author :

Publish date : 2025-10-08 12:57:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

5-Year Data: DLBCL Treatment Gets High Five

How Neuromuscular Blocker Anaphylaxis Affects Anesthesia

Initiating GLP-1 Drugs May Slightly Raise Depression Risk

Related Posts

Prevention Has a Branding Problem

Pool Data Back Safety of Newly Approved Non-Hormonal Treatment for Hot Flashes

What Vaccine Was Tied to Longer Cancer Survival?

PFAS Exposure and Brain Development; Food Insecurity and Blood Pressure

ACOG President: Changing Tylenol’s Label Will Drive Baseless Fear

Oral Tebipenem Matched IV Antibiotic for Complicated UTIs in Phase III Trial

Prevention Has a Branding Problem

Pool Data Back Safety of Newly Approved Non-Hormonal Treatment for Hot Flashes

What Vaccine Was Tied to Longer Cancer Survival?

PFAS Exposure and Brain Development; Food Insecurity and Blood Pressure

ACOG President: Changing Tylenol’s Label Will Drive Baseless Fear

Oral Tebipenem Matched IV Antibiotic for Complicated UTIs in Phase III Trial

Who Benefits From the MAHA Anti-Science Push?

Parents urged to vaccinate children as flu cases rise

Categories

Archives